Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    23927913 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Safety and Efficacy of Risedronate in the Treatment of Osteogenesis Imperfecta in Children
Condition: Osteogenesis Imperfecta
Interventions: Drug: risedronate sodium (Actonel);   Drug: Placebo

Indicates status has not been verified in more than two years